Projects

Senior Research Fellow
MMedSc Eliyahu Dremencov, DrSc

International

Current
  • Genome Editing to Treat Humans Diseases
    Program: COST
    Duration: 15. 9. 2022 – 14. 9. 2026

National

Current
  • -
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Smart deep brain stimulation as a treatment strategy in treatment-resistant depression
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • Activation of the VGF/BDNF/TrkB pathway by synthetic mRNA encapsulated in polyplex nanoparticles: effects on neural excitability, neuroplasticity and animal behavior
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
Finished
  • Novel antidepressant therapy - long term consequencies on offspring
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Investigation of the mechanism of action of novel putative antidepressant drugs: pyridoindole derivatives and trace amine-associated receptor-1 (TAAR1) ligands
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Effects of stress, induced by immune challenge during the gestation in rats, on maternal care behaviour and on hippocampal neuronal excitability in the offsprings
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Role of Neurosecretory Neurons and Calcium Signalling in Depression and Addictive Behaviour: Assessment by in-vivo Electrophysiology (SAS Scholarship Program)
    Program: Other projects
    Duration: 8. 10. 2013 – 7. 10. 2017
Employees